Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | TRT | TRT |
| Evidence strength | Moderate evidence | Moderate evidence |
| Evidence Score | 4/5 | 3/5 |
| User rating | 4.6 (187) | 4.7 (58) |
| Typical dose | Loading phase: 1000mg intramuscularly at week 0 and again at week 6. Maintenance phase: 1000mg every 10–14 weeks, individually fine-tuned based on trough levels. (The US equivalent, Aveed, uses a different dose: 750mg in 3mL, administered under the mandatory REMS program.) | There's no single universal dose — it's chosen individually to achieve a testosterone concentration in the mid-to-upper reference range for healthy young men |
| Form | Oily solution for intramuscular injection, administered only by a physician or nursing staff at a medical facility | Intramuscular/subcutaneous injections (every 1–2 weeks), transdermal gels and creams (daily), less commonly patches or subcutaneous implants |
| Average price | ok. 250–400 zł za jedną ampułkę (1000 mg/4 ml), do czego dochodzi koszt wizyty i podania w placówce medycznej | — |
| Monthly cost | przy schemacie co 10–14 tygodni — realnie ok. 60–130 zł/miesiąc uśrednionego kosztu samego leku, plus regularne koszty wizyt i badań kontrolnych | — |
| Time to effects | Trough testosterone stays within the normal range from the very first injection in clinical trials, but the full clinical effect and the stabilization of metabolite ratios (DHT, estradiol) are only established after the loading phase is complete — that is, after the second dose at week 6 and entry into the maintenance rhythm. | Libido and sexual function: 3–6 weeks. Muscle mass and strength: 3–6 months with concurrent training. Bone density: 12+ months. Mood, energy, and cognitive function: inconsistent effect, practically indistinguishable from placebo in many patients. |
| Who it's for | Men with confirmed hypogonadism who prefer a noticeably less frequent injection schedule than enanthate or cypionate | Men with at least two confirmed, morning testosterone results below the laboratory reference range |